• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX804T
Medical Device Problem Codes Excess Flow or Over-Infusion (1311); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 04/11/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that an m.Blue plus (#fx804t) was implanted during a procedure performed on (b)(6) 2023.According to the complainant, the shunt system caused an overdrainage and had adjustment difficulties.The patient underwent a revision procedure on (b)(6) 2025.No patient complications were reported as a result of the revision procedure.The complained device was not yet returned to the manufacturer for evaluation.
 
Additional Manufacturer Narrative
Manufacturing site evaluation investigation on-going.Should relevant additional information or the investigation results become available, a supplemental medwatch report will be submitted.
 
Event or Problem Description
The complained device was returned to the manufacturer for evaluation.The investigation has been completed.
 
Additional Manufacturer Narrative
Visual inspection: during the investigation, deposits/ tissue residues on the device were determined permeability test: a permeability test has shown that both valves are permeable.Computer controlled test: to investigate the claim of over-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical position.The result shows that the progav 2.0 operates within the accepted tolerances in the horizontal position.However, the m.Blue does not operate within the specified tolerances in the horizontal position.A slower outflow of m.Blue could be determined.Adjustment test: the valves were tested and both valves are not adjustable in all pressure settings.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected.However, the braking force cannot be measured due to the non-adjustability of the valves.Internal inspection: after dismantling of the valves, organic deposits were found in both valves.Results: according to the investigation results, a reduced outflow of the m.Blue in the horizontal position and a non-adjustability of both valves were detected.The visible deposits have led to the functional deviations.Deposits caused by substances naturally present in the patient's body, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of organic material can affect the integrity of the valve.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE PLUS VALVE
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key22117136
Report Number3004721439-2025-00152
Device Sequence Number4172124
Product Code JXG
UDI-Device Identifier04041906504793
UDI-Public4041906504793
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K192266
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/21/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Model NumberFX804T
Device Catalogue NumberFX804T
Device Lot Number20070962
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/06/2025
Supplement Date Received by Manufacturer05/06/2025
Initial Report FDA Received Date05/30/2025
Supplement Report FDA Received Date07/21/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age55 YR
Patient SexMale
Patient Weight73 KG
-
-